Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis

Status unconfirmed

Conditions studied: Breast Cancer

In brief

The objective is to better identify suspicious breast lesions that need to be biopsied for malignancy in women currently recommended for biopsy. The long-term goal is to reduce unnecessary biopsies and increase biopsy yield. To do this, the investigators have developed an innovative way to use FDA-approved breast imaging protocols to acquire multispectral images to measure the composition of suspicious breast lesions. The central hypothesis is that breast tissue composition in combination with analysis of morphological and textural tissue characteristics on digital breast tomosynthesis (DBT) imaging will yield significantly higher breast cancer specificity than conventional interpretation of DBT alone.

Key facts

Study ID
NCT05369546
Run by
University of Hawaii
People needed
600
Starts
2022-08-01
Expected to finish
2026-07-01
Last updated by the study team
2023-02-02

Who can join

Age: 20 and older, up to 85. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.